| Company/Division name | Jubilant HollisterStier |
| Parent company | Jubilant Pharma Limited |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 200 |
| Year reshoring announced: | 2024 |
| Domestically, the work will be done: | In-house |
| Country(ies) from which reshored: | India |
| City reshored to: | Spokane |
| State(s) reshored to: | WA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | sterile injectables, ophthalmics, otics, topicals |
| What domestic positive factors made reshoring more attractive? | Automation/technology, Customization/Flexibility, Government Incentives, Higher productivity, Lead time/Time to market, Fed funds: DHHS ASPR and BARDA |
